Physician profile
Dong Ko
NPI 1629066329
$8,127.15
in general payments reported to CMS, 2019-2025
42 companies · $1,372 in 2025
The $1,372 reported for 2025 was more than what 79% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,071 · 2020: $784 · 2021: $728 · 2022: $906 · 2023: $1,099 · 2024: $1,167 · 2025: $1,372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,638.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $1,889.86 | 2019-2025 | Xtampza, Belbuca |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,775.99 | 2019-2025 | Relistor, Xifaxan |
| Pfizer INC. | $663.07 | 2019-2025 | |
| Scilex Pharmaceuticals INC. | $582.16 | 2019-2023 | Ztlido |
| Medtronic USA, INC. | $483.20 | 2019-2020 | |
| Medtronic, INC. | $423.77 | 2021-2025 | Inceptiv |
| Redhill Biopharma INC. | $247.85 | 2020-2022 | |
| Tersera Therapeutics LLC | $235.51 | 2019-2025 | Prialt |
| Kowa Pharmaceuticals America, INC. | $160.37 | 2022-2023 | Seglentis |
| Teva Pharmaceuticals USA, INC. | $156.24 | 2019-2022 | |
| Mml US, INC. | $151.10 | 2023 | Reactiv8 |
| Abbvie INC. | $133.12 | 2022-2025 | |
| Mdd US Operations, LLC | $124.00 | 2019 | |
| Biodelivery Sciences International, INC. | $99.21 | 2020-2021 | |
| Vertex Pharmaceuticals Incorporated | $90.35 | 2024-2025 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dong Ko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.